Avastin 1 recalled over sterility concerns
- Recall date
- February 18, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Turbare Manufacturing recalls Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single…
- Recall number
- D-0248-2025
- FDA classification
- Class II
- Brand / firm
- Turbare Manufacturing
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility: due to a quality control process deviation
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Get recall alerts
Free email alert whenever Turbare Manufacturing has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Turbare Manufacturing